Otrivin - 0.05% or 0.1% Nasal Drops 15 ml

Acute respiratory diseases with symptoms of rhinitis; Acute allergic rhinitis; Pollinosis; Sinusitis; Eustachitis; Otitis media (to reduce swelling of the nasopharyngeal mucosa); Preparing the patient for diagnostic manipulations in the nasal passages, including rhinoscopy.

Trade name:

Otrivin

Otrivin

Composition and form of release:

Nasal drops 0.05% contain 0.05 mg \ 1 ml of Xylometazoline hydrochloride.

Nasal drops 0.1% contain 0.1 mg \ 1 ml of Xylometazoline hydrochloride.

Nasal drops, plastic bottle.

Pharmachologic effect:

Xylometazoline has an alpha-adrenomimetic effect: it causes narrowing of the blood vessels of the nasal mucosa, eliminating edema and hyperemia of the nasopharyngeal mucosa. Xylometazoline also reduces concomitant mucus hypersecretion and facilitates drainage of blocked nasal passages and thus improv nasal breathing in case of nasal congestion. Otrivin is well tolerated by patients with sensitive mucous membranes; its effect does not prevent mucus separation.

In therapeutic concentrations, the drug does not irritate the mucous membrane, does not cause hyperemia.

The effect occurs within a few minutes after application and lasts for 12 hours.

Indications:

Acute respiratory diseases with symptoms of rhinitis; Acute allergic rhinitis; Pollinosis; Sinusitis; Eustachitis; Otitis media (to reduce swelling of the nasopharyngeal mucosa); Preparing the patient for diagnostic

manipulations in the nasal passages, including rhinoscopy.

Contraindications:

Hypersensitivity to xylometazoline and other components of the drug; Arterial hypertension; Tachycardia; Severe atherosclerosis; Glaucoma; Dry rhinitis or atrophic rhinitis; Hyperthyroidism; Condition after transsphenoidal hypophysectomy; Surgical interventions on the meninges (in history); Children under 12 years old for Otrivin 0.1%; Children under 1 year old for Otrivin 0.05%. With care: diabetes mellitus; pheochromocytoma; cardiovascular diseases (including ischemic heart disease, angina pectoris); hyperplasia of the prostate; with hypersensitivity to adrenergic drugs, accompanied by insomnia, dizziness, arrhythmia, tremor, increased blood pressure.

Application during pregnancy and lactation:

The drug should not be used during pregnancy.

During lactation, use is possible only under the supervision of a physician and after a careful assessment of the risk-benefit ratio for the mother and the fetus. Do not exceed the recommended dose.

Side effects:

Determination of the frequency of adverse reactions: very often 210); often (21 / 100,

<1/10); infrequently (21 / 1000, < 1/100); rarely ( 2 1/10 000, <1/1000); very rare (<1/10 000).

From the immune system: very rarely hypersensitivity reactions (angioedema, rash, itching).

From the nervous system: often — headache; rarely — insomnia, depression (with prolonged use in high doses).

From the senses: very rarely — a violation of the clarity of visual perception.

From the side of the cardiovascular system: rarely — a feeling of palpitations, increased blood pressure; very rarely — tachycardia, arrhythmia.

From the respiratory system: often — irritation and / or dryness of the nasopharyngeal mucosa, burning, tingling, sneezing, hypersecretion of the nasopharyngeal mucosa.

From the digestive system: often — nausea; rarely — vomiting.

Local reactions: often — burning at the site of application.

If any of the above side effects are aggravated, or the patient has noticed any other side effects, he should inform the doctor about it.

Dosing regimen:

Intranasally.

Otrivin 0.1%:

Adults and children over 12 years old: 2-3 drops in each nasal passage as needed, up to 3-4 times / day.

It is recommended to apply one last time just before bedtime.

Otrivin 0.05:

Children aged 1-2 years should only be used as directed by a doctor.

Children aged 2-11 years: 1-2 drops in each nostril 1-2 times a day. The maximum

frequency of use is 3 times a day.

It is not recommended to use it continuously for more than 10 days, since prolonged or excessive use of the drug can cause a rebound effect (rhinitis medicamentosa) and / or atrophy of the nasal mucosa.

Storage method:

Keep out of the reach of children at a temperature not exceeding 25 degrees.

Packaging:

The cardboard box contains a 15 ml bottle, paper instructions.